BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 7, 2003
View Archived Issues
Santarus Reports Success With SAN-05 Phase III In GI Bleeding
Santarus Inc. hit a fairly high hurdle in its SAN-05 Phase III trial, and partially unveiled early positive results. (BioWorld Today)
Read More
BioSante Raises $10.3M To Fund Phase III Study Of Estrogen Gel
Read More
Latest Model Ebola Virus Vaccine Rescues Monkeys' Lives; People Version Possibly' Two Years Off
Read More
Cellegy Gets Cellegesic Back On Track With New Phase III
Read More
Correction
Read More
Other News To Note
Read More
Appointments And Advancements
Read More